Thailand HIV and Stigma Reduction Study
Recruiting now · Not applicable
Conditions studied: Pre-Exposure Prophylaxis
In brief
This project will develop a multi-component, technology-delivered intervention designed to reduce HIV and intersectional stigma and improve the use of HIV pre-exposure prophylaxis (PrEP) among HIV-negative Thai vulnerable emerging adults (18-29 years).
Key facts
- Study ID
- NCT06576648
- Run by
- University of Massachusetts, Worcester
- People needed
- 154
- Starts
- 2025-02-20
- Expected to finish
- 2027-08-14
- Last updated by the study team
- 2025-09-08
Who can join
Age: 18 and older, up to 29. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- Ages between 18 and 29 years
- Male sex at birth
- Self-identifies as women, transgender women or culturally identifies with the female spectrum
- Laboratory-confirmed HIV-negative status
- Self-reported recent history of condomless sex
- Able to understand, read and speak Thai
- Either not started PrEP or currently on PrEP but not adherent (taking ≤3 pills/week) in the past month.
You may not qualify if…
- Have a serious cognitive or psychiatric problem compromising ability to provide informed consent
- Have active suicidal ideation or major mental illness at the time of interview (these patients will be referred for treatment)
- Laboratory or clinical findings that would preclude PrEP initiation (e.g., decreased creatinine clearance)
- Currently enrolled in another HIV intervention study.
- Healthcare providers Inclusion criteria
- Age 18 or above
- Has provided HIV prevention or treatment services for TGW for at least one year Exclusion criteria
- None
- Aim 2 (Pilot RCT) Transgender women Inclusion criteria
- Ages between 18 and 29 years
- Male sex at birth
- Self-identifies as women, transgender women or culturally identifies with the female spectrum
- Laboratory-confirmed HIV-negative status
- Self-reported recent history of condomless sex
- Able to understand, read and speak Thai
- Either not started PrEP or currently on PrEP but not adherent (taking ≤3 pills/week) in the past month.
- Exclusion criteria
- Have a serious cognitive or psychiatric problem compromising ability to provide informed consent
- Have active suicidal ideation or major mental illness at the time of interview (these patients will be referred for treatment)
- Laboratory or clinical findings that would preclude PrEP initiation (e.g., decreased creatinine clearance)
- Currently enrolled in another HIV intervention study.
Where it is running
- Institute of HIV Research and Innovation — Bangkok, Thailand (enrolling)
- Rainbow Sky Association of Thailand — Bangkok, Thailand (enrolling)
- SWING Foundation — Bangkok, Thailand (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.